Dr. Jairath is Associate Professor of Medicine, Epidemiology and Biostatistics. He trained at Leeds University in England and did his specialist training in gastroenterology in London and Oxford. Prior to moving to Western in 2016, he was a consultant gastroenterologist at Oxford University hospitals and a lecturer at Oxford University, with career funding from the National Institute for Health Research. He has a degree in pharmacology (Leeds University), a diploma in clinical trials (London School of Hygiene and Topical Medicine) and a PhD (Oxford University). His research interests are in the design, conduct and implementation of randomized controlled trials and he has been a leader and collaborator in several trials over the past few years. He has successfully obtained several peer reviewed grants from government funding agencies to conduct clinical studies. He is the recipient of awards for his clinical and research endeavours and supervises several students and research fellows.
Dr. Jairath’s clinical practice is based at University hospital, London, Ontario. Patients with Crohn’s Disease and Ulcerative colitis will be cared for by a multi-disciplinary team including a specialist nurse, dietician and access to specialists in colorectal surgery and nutrition.
Dr. Jairath is Director of Medical Research and Development at Robarts Clinical Trials, a global academic Clinical Research Organization which provides a broad range of clinical research services to pharmaceutical and biotechnology companies, government agencies and academic investigators. It is a wholly owned subsidiary of Western University and reinvests profits into research and development to advance scientific research in Crohn’s Disease and Ulcerative Colitis. He holds professional memberships with the College of Physicians and Surgeons of Ontario, Royal College of Physicians (UK), British Society of Gastroenterology, American Gastroenterology Association, Canadian Association of Gastroenterology and. He was past Scientific Officer of ClinCom (Clinical trials committee) of the European Crohn’s and Colitis Organization.